Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

Vaccine

Volumn 20, Issue 5-6, 2001, Pages 895-904

  Wu, Cheng Nan ^a,b   Lin, Ya Ching ^b   Fann, Cathy ^b   Liao, Nan Shih ^c   Shih, Shin Ru ^d   Ho, Mei Shang ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

DNA vaccine; Enterovirus 71; Subunit VP1 vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN SUBCLASS; INACTIVATED VIRUS VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN VP1; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; HELPER CELL; IMMUNE RESPONSE; INFECTION CONTROL; LD 50; LETHALITY; LYMPHOCYTE PROLIFERATION; MOUSE; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; VACCINE PRODUCTION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; CHILD; CYTOKINES; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED ICR; MICE, KNOCKOUT; NEUTRALIZATION TESTS; PLASMIDS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA; VACCINES, INACTIVATED; VACCINES, SUBUNIT; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 0035852349     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00385-1     Document Type: Conference Paper

References (48)

1. An apparently new enterovirus isolated from patients with disease of the central nervous system
2. Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection
3. Investigation of physicochemical properties of Bulgarian strain 258 of enterovirus type 71. Brief report
4. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria
5. Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997
6. Deaths among children during an outbreak of hand, foot, and mouth disease - Taiwan, Republic of China, April-July 1998
7. An epidemic of enterovirus 71 infection in Taiwan. Taiwan enterovirus epidemic working group
8. Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil
9. Prevention of acute and chronic liver disease through immunization: Hepatitis B and beyond
10. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model
11. A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B-cells in mice
12. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
13. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates
14. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice
15. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: A comparative study with conventional viral vaccines
16. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2
17. Protection of mice against lethal Coxsackievirus B3 infection by using DNA immunization
18. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998
19. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions
20. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus
21. Neutralization of aggregated strains of enterovirus 71 and echovirus type 4 in RD and Vero or GMK-AH1 cells
22. Indirect enzyme-linked immunosorbent assay (ELISA) for the detection of Coxsackievirus group B antibodies
23. Isolation and immunizations with hepatitis A viral structural proteins: Induction of antiprotein, antiviral, and neutralizing responses
24. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides
25. Poliovirus neutralization epitopes: Analysis and localization with neutralizing monoclonal antibodies
26. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3
27. Antigenicity and immunogenicity of poliovirus capsid proteins
28. Expression of poliovirus capsid polypeptide VP1 in Escherichia coli
29. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1
30. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants
31. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon
32. T-cell-independent type I antibody response against B-cell epitopes expressed repetitively on recombinant virus particles
33. The influence of virus structure on antibody responses and virus serotype formation
34. Subunit vaccines against enveloped viruses: Virosomes, micelles and other protein complexes
35. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules
36. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules
37. Presentation of an exogenous antigen by major histocompatibility complex class I molecules
38. The structure of Coxsackievirus B3 at 3.5 A resolution
39. Implications for viral uncoating from the structure of bovine enterovirus
40. Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: Clustering of amino acid difference identifies possible locations of immunogenic sites on the virion
41. Preparation and characterization of the monoclonal antibodies against Japanese encephalitis virus
42. Modulating the immune response to genetic immunization
43. + T-cells
44. Functional diversity of T-lymphocytes due to secretion of different cytokine patterns
45. The humoral immune response
46. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis
47. Common antigen between Coxsackievirus A 16 and enterovirus 71
48. Seroepidemiology of enterovirus 71 among healthy children near Tokyo